Julie A Schneider Selected Research

complexin II

5/2021	Tripartite Relationship Among Synaptic, Amyloid, and Tau Proteins: An In Vivo and Postmortem Study.
1/2019	The synaptic pathology of cognitive life .
1/2017	Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie A Schneider Research Topics

Disease

102	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 03/2004
73	Cognitive Dysfunction 02/2022 - 03/2004
52	Dementia (Dementias) 07/2022 - 01/2006
27	Amyloid Plaque 01/2022 - 01/2011
25	Hippocampal Sclerosis 06/2022 - 01/2012
18	Infarction (Infarctions) 01/2022 - 01/2012
17	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 06/2022 - 01/2014
12	Cerebral Infarction 01/2020 - 01/2006
9	Atherosclerosis 10/2022 - 01/2017
9	Arteriolosclerosis 01/2022 - 08/2017
8	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 02/2022 - 07/2007
7	Brain Diseases (Brain Disorder) 01/2022 - 10/2020
7	limbic-predominant age-related TDP-43 encephalopathy 01/2022 - 01/2019
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 04/2005
7	Lewy Body Disease (Lewy Body Dementia) 01/2021 - 01/2012
6	Proteostasis Deficiencies 01/2022 - 11/2016
6	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021 - 12/2013
5	Parkinsonian Disorders (Parkinsonism) 10/2022 - 01/2016
5	Brain Infarction 01/2022 - 01/2013
5	TDP-43 Proteinopathies 01/2021 - 07/2007
4	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 10/2022 - 01/2020
4	Frontotemporal Dementia (Semantic Dementia) 01/2022 - 07/2007
4	Amyloid angiopathy 01/2021 - 11/2015
3	Vascular Diseases (Vascular Disease) 01/2022 - 08/2008
3	Stroke (Strokes) 04/2021 - 02/2015
3	Disease Progression 01/2021 - 02/2008
3	Tauopathies 01/2021 - 12/2014
3	Atrophy 01/2018 - 05/2014
3	Parkinson Disease (Parkinson's Disease) 01/2016 - 01/2007
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2022 - 01/2018
2	Inflammation (Inflammations) 01/2021 - 01/2019
2	Amyloidosis 01/2021 - 01/2018
2	Sleep Deprivation 12/2019 - 10/2014
2	Hypokinesia (Bradykinesia) 01/2016 - 01/2007
2	Synucleinopathies 07/2015 - 02/2013
2	Cerebrovascular Trauma 01/2012 - 01/2012
2	Motor Neuron Disease (Primary Lateral Sclerosis) 07/2007 - 07/2007
1	Mixed Dementias 01/2022
1	Hemorrhage 01/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022

Drug/Important Bio-Agent (IBA)

62	Amyloid (Amyloid Fibrils)IBA 02/2022 - 03/2004
36	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2022 - 07/2007
29	Apolipoproteins E (ApoE)IBA 06/2022 - 04/2009
29	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2007
17	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2011
12	ApolipoproteinsIBA 04/2021 - 08/2007
11	Amyloid beta-PeptidesIBA 06/2022 - 01/2007
8	SilverIBA 06/2022 - 05/2006
6	Biological ProductsIBA 01/2022 - 08/2006
6	RNA (Ribonucleic Acid)IBA 11/2020 - 01/2016
5	ProgranulinsIBA 02/2022 - 07/2007
5	Coloring Agents (Dyes)IBA 01/2022 - 05/2006
5	SynucleinsIBA 01/2022 - 07/2012
5	florbetapirIBA 10/2014 - 01/2011
4	VitaminsIBA 01/2021 - 04/2005
4	Messenger RNA (mRNA)IBA 01/2021 - 03/2007
4	Folic Acid (Vitamin M)FDA LinkGeneric 08/2006 - 04/2005
3	CholesterolIBA 07/2022 - 04/2012
3	Peptides (Polypeptides)IBA 01/2022 - 01/2019
3	complexin IIBA 05/2021 - 01/2017
3	complexin IIIBA 05/2021 - 01/2017
3	Hemoglobins (Hemoglobin)IBA 04/2021 - 01/2012
3	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 01/2014
3	Vitamin E FDA LinkGeneric 01/2020 - 08/2006
3	Antipsychotic Agents (Antipsychotics)IBA 08/2008 - 01/2006
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 05/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2020
2	LigandsIBA 01/2021 - 01/2012
2	IronIBA 01/2021 - 11/2020
2	Insulin (Novolin)FDA Link 01/2021 - 01/2020
2	Tocopherols (Tocopherol)IBA 01/2020 - 01/2015
2	LipidsIBA 09/2019 - 01/2019
2	Amyloidogenic ProteinsIBA 01/2019 - 01/2017
2	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2006
2	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 08/2008
2	HomocysteineIBA 01/2018 - 08/2006
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2017 - 02/2016
2	Protein Isoforms (Isoforms)IBA 01/2016 - 02/2008
2	Complement System Proteins (Complement)IBA 01/2016 - 04/2009
2	Antiphospholipid AntibodiesIBA 01/2015 - 01/2013
2	UbiquitinIBA 07/2007 - 07/2007
2	Valosin Containing ProteinIBA 07/2007 - 07/2007
2	Niacin (Nicotinic Acid)FDA LinkGeneric 08/2006 - 08/2006
1	LDL CholesterolIBA 06/2022
1	oxidized low density lipoproteinIBA 06/2022
1	Aligeron (AS 2)IBA 01/2022
1	Vitamin K FDA Link 01/2022
1	Anthocyanins (Anthocyanin)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	Caffeine (No Doz)FDA LinkGeneric 01/2022
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022
1	CalciumIBA 01/2022
1	A 17 (A-17)IBA 01/2022
1	pelargonidinIBA 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2022

Therapy/Procedure

2	Dietary Approaches To Stop Hypertension 07/2022 - 01/2021
2	Therapeutics 02/2022 - 11/2020
2	Mediterranean Diet 01/2021 - 10/2014
2	Activities of Daily Living (ADL) 09/2017 - 01/2007